FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/032156 [Registered on: 19/03/2021] Trial Registered Prospectively
Last Modified On: 18/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   ketaki basti in diabetetes mellitus-2 
Scientific Title of Study   A controlled clinical study to evaluate the effect of Ketaki mula niruha basti and madhutailika basti in madhumeha with special reference to diabetes mellitus-2 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Akshatha M 
Designation  PG Scholar 
Affiliation  Government ayurveda medical college 
Address  Department of panchakarma, Opd no. 6A,Government ayurveda medical college, Bengaluru-09

Bangalore
KARNATAKA
560009
India 
Phone  7892373925  
Fax    
Email  akshatham77@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ananta S desai 
Designation  Guide and HOD 
Affiliation  Government ayurveda medical college 
Address  Department of panchakarma, OPD no-6A, Government ayurveda medical college, Bengaluru-09

Bangalore
KARNATAKA
560009
India 
Phone  9448185896  
Fax    
Email  anantdesai30@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Akshatha M 
Designation  PG Scholar 
Affiliation  Government ayurveda medical college 
Address  Department of panchakarma, OPD no-6A, Government ayurveda medical college,Bengaluru-09

Bangalore
KARNATAKA
560009
India 
Phone  7892373925  
Fax    
Email  akshatham77@gmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Dr Akshatha M 
Address  department of panchakarma, OPD no.6A Government ayurveda medical college, Bengaluru-09 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR AKSHATHA M  SRI JAYACHAMARAJENDRA INSTITUTE OF INDIAN MEDICINE HOSPITAL  DEPARTMENT OF PANCHAKARMA OPD NO.6A GOVERNMENT AYURVEDA BENGALURU-09
Bangalore
KARNATAKA 
7892373925

akshatham77@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee, government ayurveda college Bengaluru 09  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E119||Type 2 diabetes mellitus without complications. Ayurveda Condition: MADHUMEHAH/KSHAUDRAMEHAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1.Ketaki niruha basti  1.ketaki niruha basti with murchita tila taila for anuvasana in yoga basti pattern. Dose: Ketakimoola niruha basti- 562 ml Anuvasana basti - 40ml Route of administration-rectal route. Duration-25days  
Comparator Agent  Madhutailika basti  Madhutailika basti is administered in yoga basti pattern. Dose:Madhutailika basti- 628 ml Anuvasana basti - 40ml Route of administration:Rectal route Duration-25days 
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Post prandial blood sugar (ppbs) level between 160-280 mg/dL.
HbA1C level between 6.5%-11%.
 
 
ExclusionCriteria 
Details  1.Subjects with type 2 diabetes mellitus who are insulin dependent.
2.Subjects who are diagnosed to have complications like diabetic foot, diabetic retinopathy
and other secondary complications.
3.Other complications like cardiac, hepatic and renal complications.
4.Pregnant and lactating woman. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Polyurea
Polyphagia
Polydipsia 
25 days 
 
Secondary Outcome  
Outcome  TimePoints 
Fasting blood sugar  25 Days 
Post prandial blood sugar  25 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/03/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Prameha is a tridoshaja vyadhi,4 produced due to over indulgence in heavy, richly nutritious food, day sleep, lack of cleanliness, exercises and other sedentary habits.5 Madhumeha is one among the types of prameha.6 It is one among astamahagada.7,8 It is a anushangi vikara.9 Diabetes mellitus-2 can be equated with madhumeha as both have similar etiologies, symptoms and complications. Global prevalence of Diabetes mellitus is estimated to be around 374 million in 2017 and projected to increase to 587 million adults by 2045 equalling 8.4% of total population. It is more prevalent in low and middle income countries.10 Its incidence is also increasing at an alarming rate. There were 65 million prevalent cases of diabetes in India in 2016.11 It Has become of utmost importance to find ways to combat this disease. Ketaki is one among wide variety of the drugs which has been described in the treatment of meha.12 It is easily available, cost effective. Traditionally the roots of ketaki believed to have antidiabetic, antidiuretic, cardiotonic and aphrodisiac properties.13 Madhutailika basti can be administered to the person who desires to take niruha basti. 14 It is one among the bastis told by samhita in the treatment of meha.15A study has been conducted on the effect of madhutailika basti in management of madhumeha by Doddabasayya S Swamy and it found statistically significant result, hence this study, “A controlled clinical study to evaluate the effect of Ketakimoola niruha basti and Madhutailika basti in madhumeha w.s.r.t Diabetes mellitus-2”, aims to assess the madhumehahara karma of Kethakimoola niruha basti and Madhutailika basti, and to find better treatment among these.
HYPOTHESIS
 H0: There is no difference in the effect of Ketaki niruha basti and Madhutailika basti in madhumeha.
 H1: There is difference between effect of Ketaki Moola niruha basti and Madhutailika basti in madhumeha.
 
Close